ENOXAPARIN SODIUM β SANDOZ, approved 2024-06-14 (ANDA077857).
29,638 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System β they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.